A detailed history of Bryn Mawr Trust CO transactions in Cabot Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 9,592 shares of CBT stock, worth $590,867. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,592
Previous 14,643 34.49%
Holding current value
$590,867
Previous $1.11 Million 34.5%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 20, 2025

SELL
$72.0 - $82.94 $363,672 - $418,929
-5,051 Reduced 34.49%
9,592 $729,000
Q3 2025

Oct 28, 2025

SELL
$72.0 - $82.94 $5,400 - $6,220
-75 Reduced 0.51%
14,643 $1.11 Million
Q4 2024

Jan 28, 2025

SELL
$90.64 - $117.0 $5,075 - $6,552
-56 Reduced 0.38%
14,718 $1.34 Million
Q3 2024

Nov 25, 2024

BUY
$86.96 - $111.73 $1.28 Million - $1.65 Million
14,774 New
14,774 $1.65 Million

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $3.47B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.